Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia
Open Access
- 10 November 2005
- journal article
- Published by Springer Nature in Leukemia
- Vol. 19 (12) , 2232-2240
- https://doi.org/10.1038/sj.leu.2404009
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- BRAF mutations in acute leukemiasLeukemia, 2003
- The role of FLT3 in haematopoietic malignanciesNature Reviews Cancer, 2003
- Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemiaBlood, 2003
- Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemiasBritish Journal of Haematology, 2003
- GENETICS OF MYELOID LEUKEMIASAnnual Review of Genomics and Human Genetics, 2002
- The roles of FLT3 in hematopoiesis and leukemiaBlood, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AMLLeukemia, 2002
- Oncogenic kinase signallingNature, 2001
- Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesBlood, 2001